It's too late for Lenin, but the University of Pennsylvania's high-resolution MRI scan of a dead person's brain is full of detail. Ex vivo MRI of the brain provides remarkable advantages over in vivo ...
(RTTNews) - Lexeo Therapeutics, Inc. (LXEO) Wednesday reported positive interim results from the Phase 1/2 study of its gene therapy candidate LX1001 for the treatment of APOE4-associated Alzheimer's ...
The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety of datopotamab deruxtecan (Dato-DXd)-based combinations in patients with locally ...